Derisk Early and Accelerate Antibody Development With Mass Photometry

In this recent presentation given by our Product Manager, Stephen Maughan, DPhil, he uses real-world data and case studies to demonstrate how mass photometry streamlines development projects involving mAbs, BsAbs, and ADCs – and how it compares to SEC.